ROSEN, LEADING INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AKRO

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Akero Therapeutics, Inc. between September 13, 2022...

Related Keywords

China ,Chinese ,Laurence Rosen ,Phillip Kim ,Rosen Law Firm ,Twitter ,Linkedin ,Nasdaq ,Us Food Drug Administration ,Akero Therapeutics Inc ,Facebook ,Chinese Company ,Securities Class Action Services ,Akero Therapeutics ,Class Period ,Law Firm ,Class Action Services ,Non Alcoholic Steatohepatitis ,Drug Administration ,Class Has Been ,Markets ,